@Popeye82 No I don't work in the area - I workin Finance. No one...

@Popeye82 No I don't work in the area - I workin Finance. No one on this thread seems to have scientific background, Irely mostly on what the company says. For me, that it is modelled on somethingnaturally occurring in the human body, and the safety profile of peptides (asdetailed in the prospectus) and many company statements have said its safe andwell tolerated at high levels. What it will do in humans? Who knows. But my betis that because this is already occurring in our immune system, turbocharged, that it will be a success. IMO we are in the quiet before thestorm. I like to be early, but I am not patient.. Once these 4 Ph2 trialskick off, we will be straight to the races. Biggest risk from here is ifmanagement can re-write their history of missing deadlines and start to deliverOTIF. & thanks re IHL, those two posters I baited in my last post played nosmall part in that, they are next level and I hope our forum can attractposters of their caliber.

Goodluck